Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

01

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

02

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

03

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub
Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

8,237 stories indexed, page 55 of 138

🇺🇸Industryvikingtherapeutics.com
Featured signal

VANQUISH-2: Phase 3, Randomized, Double-blind, Placebo-controlled, Trial of weekly subcutaneous administration of VK2735 in Obese or Overweight Adults with Type 2 Diabetes - Viking Therapeutics

Publisher

Viking Therapeutics (IR)

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

Viking Therapeutics (IR)Original publisher link

Canonical metadata stays public, while full text remains on the original site.

🇺🇸Industryvikingtherapeutics.com

Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study - Viking Therapeutics

Viking Therapeutics (IR)Original source
🇬🇧Researchmed.cam.ac.uk

New vulnerability identified in common kidney cancer could open door to new treatments

University of Cambridge - Clinical Medicine NewsOriginal source
🌍Industryamarin.co.th

บริษัท อมรินทร์ คอร์เปอเรชั่นส์ จำกัด (มหาชน) และกลุ่มบริษัทในเครือ ร่วมเป็นเจ้าภาพบำเพ็ญพระราชกุศลถวายพระบรมศพ ณ พระที่นั่งดุสิตมหาปราสาท

Amarin CorporationOriginal source
🇫🇷Industrycellectis.com

Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

CellectisOriginal source
🌍Industrynervgen.com

NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange

NervGen PharmaOriginal source
🌍Industrycibeles.com.uy

Facily 144sc

Cibeles (Uruguay)Original source
🌍Industrycibeles.com.uy

Grünöl

Cibeles (Uruguay)Original source
🌍Industrycibeles.com.uy

Cerio 75wg

Cibeles (Uruguay)Original source
🌍CROcrucialdatasolutions.com

API Integrations in Clinical Trials: How Modern Platforms Enable Connected Clinical Data Systems and Flexible Study Workflows

TrialKitOriginal source
🇨🇭CDMObachem.com

Bachem reports strong sales growth and sustained high profitability

Bachem PeptidesOriginal source
🌍Researchunityhealth.to

Meet Dr. Dalia Rotstein, the St. Michael’s neurologist dedicated to improving care for women during pregnancy

St. Michael's Hospital (Toronto)Original source
🌍Mediaproscia.com

What Proscia’s Top KLAS Ratings Mean for Life Sciences Companies

ProsciaOriginal source
🇯🇵Industrynippon-shinyaku.co.jp

「厚木営業所」移転のお知らせ

Nippon Shinyaku NewsOriginal source
🌍Associationasn-online.org

World Kidney Day - #SockItToKidneyDisease

American Society of NephrologyOriginal source
🇬🇧Researchuclh.nhs.uk

NHS Staff Survey 2025 – we're the top recommended place to work for fourth year running!

University College London Hospitals (UCLH)Original source
🌍Industryrelmada.com

Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026

Relmada TherapeuticsOriginal source
🌍Mediaevaluate.com

Orphan Drugs at a Crossroads: Bigger Numbers, Tougher Calls

Evaluate VantageOriginal source
🇪🇸Researchcrg.eu

Scientists find new way of measuring activity of cell editors that fuel cancer

CRG Barcelona GenomicsOriginal source
🌍Industryamarin.co.th

Amarin Group ร่วมกับชุมชน จัดกิจกรรมบริจาคโลหิต ครั้งที่ 1 ประจำปี 2569

Amarin CorporationOriginal source
🇯🇵pharma_equipmentprodcms.ulvac.co.jp

Sales Termination of High-Speed Spectroscopic Ellipsometer UNECS

Ulvac (Pharma)Original source
🇯🇵pharma_equipmentprodcms.ulvac.co.jp

Presentation at the 73rd JSAP Spring Meeting 2026

Ulvac (Pharma)Original source
🌍Regulatorytransceleratebiopharmainc.com

From Vision to Value: A Blueprint for Implementing Industry Consortia Innovations

TransCelerate BioPharmaOriginal source
🌍Mediavariational.ai

Variational AI to Participate in the MaRS Impact Health Summit

Variational AIOriginal source
🌍Mediavariational.ai

Variational AI to Participate in the Bloom Burton Healthcare Investor Conference

Variational AIOriginal source
🇺🇸Industryir.codexis.com

Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results

CodexisOriginal source
🇺🇸Industrysolidbio.com

Letter to the Duchenne Community

Solid BiosciencesOriginal source
🇯🇵CROen.cmicgroup.com

CMIC Earns SBT Certification for Its Greenhouse Gas Reduction Targets — Driving Forward Its Decarbonization Commitment

CMIC Group JapanOriginal source
🇬🇧Researchuclh.nhs.uk

UCLH and UCL researchers trial proton beam therapy in bid to transform treatment for mesothelioma

University College London Hospitals (UCLH)Original source
🇩🇪Researchcharite.de

Active ingredient of Viagra helps treat rare genetic disease

Charité - Universitätsmedizin Berlin (EN)Original source
🇬🇧Researchmed.cam.ac.uk

Age-related blood cell mutations affect heart disease risk in different ways, study finds

University of Cambridge - Clinical Medicine NewsOriginal source
🇯🇵Industrynippon-shinyaku.co.jp

CAP-1002：新たなPDUFA dateが設定されたことをカプリコール社が発表

Nippon Shinyaku NewsOriginal source
🌍Mediaprecisionformedicine.com

Precision for Medicine Continues Asia-Pacific Expansion with Opening of Japan Office

Precision for MedicineOriginal source
🇺🇸Devicespathai.com

PathAI Expands AISight® Dx with the v2.19 Release: Enhancing Flexibility, Collaboration, Reporting and Workflow Precision

PathAIOriginal source
🇺🇸Researchfrazierls.com

Vima Therapeutics Announces First Dystonia Patient Dosed in Phase 2 Study and Extension of Series A to $100 Million to Advance Potential First-in-Class Oral Therapy for Dystonia and Parkinson’s Disease

Frazier Life SciencesOriginal source
🌍Industrysubtlemedical.com

Subtle Medical to Showcase AI Innovations at NVIDIA GTC 2026

Subtle MedicalOriginal source
🌍Mediavariational.ai

Variational AI to speak at ALL IN Talks West

Variational AIOriginal source
🌍Industryskyebioscience.com

2025 Year-end & Q4 Financial Results and Update

Skye BioscienceOriginal source
🇺🇸CDMOcookmedical.com

Cook Medical selects Indiana University as Interventional MRI Center of Excellence

Cook PharmicaOriginal source
🇯🇵CROen.cmicgroup.com

CMIC Partners with Bluenote to Transform Clinical Development Operations with Agentic AI

CMIC Group JapanOriginal source
🌍Industrybenitec.com

Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development for Oculopharyngeal Muscular Dystrophy (OPMD)

Benitec BiopharmaOriginal source
🌍Industryuk-cpi.com

From chemistry to component: New NCC and CPI partnership to strengthen UK materials capability

CPI (Healthcare Innovation)Original source
🌍Devicesaiforia.com

Aiforia and Proscia partner to accelerate AI-driven digital pathology

AiforiaOriginal source
🇯🇵Deviceshoya.com

健康経営優良法人に10年連続で認定

HOYA MedicalOriginal source
🇺🇸Devicesapyxmedical.com

Apyx Medical Corporation Reports Fourth Quarter And Full Year 2025 Financial Results

Apyx MedicalOriginal source
🌍Industryrelmada.com

Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference

Relmada TherapeuticsOriginal source
🇯🇵Industrynippon-shinyaku.co.jp

「健康経営銘柄2026」に初選定、「ホワイト500」は6年連続で認定

Nippon Shinyaku NewsOriginal source
🇺🇸CDMOcookmedical.com

Cold AcuSnare Polypectomy Snare and Caesar Alligator Rat Tooth Grasping Forceps now available

Cook PharmicaOriginal source
🌍Industryrelmada.com

Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing

Relmada TherapeuticsOriginal source
🌍Industryrelmada.com

Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer

Relmada TherapeuticsOriginal source
🌍Industrybenitec.com

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference

Benitec BiopharmaOriginal source
🌍Industrymenicon.com

Menicon Renames Its Sales Subsidiary in China - Aiming for brand value enhancement and sales expansion -

MeniconOriginal source
🌍Industryrss.globenewswire.com

ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization

ARS PharmaceuticalsOriginal source
🇺🇸Researchnewsroom.clevelandclinic.org

Why Cleveland Clinic Is Expanding Trauma Care in Cleveland

Cleveland Clinic Main CampusOriginal source
🇯🇵Researchriken.jp

Remembering Anthony J. Leggett (1938-2026)

RIKENOriginal source
🌍Researchectrims.eu

Call for Submissions – Rachel Horne Prize for Women’s Research in MS 2026

ECTRIMS MSOriginal source
🇺🇸Regulatoryciscrp.org

Journey to Better Health: Driving Change in Clinical Research

CISCRP Patient InfoOriginal source
🇺🇸Industrybrukercellularanalysis.com

AI Functional Antibodies: From Design to Cell Binding Candidates

Berkeley LightsOriginal source
🌍Industryadial.com

Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update

Adial PharmaceuticalsOriginal source
🌍Researchpnas.org

Short strands of RNA nearly self-replicate, recreating a possible step in the dawn of life

PNASOriginal source